BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 37049419)

  • 1. Identification of Natural Compounds of the Apple as Inhibitors against Cholinesterase for the Treatment of Alzheimer's Disease: An In Silico Molecular Docking Simulation and ADMET Study.
    Jamal QMS; Khan MI; Alharbi AH; Ahmad V; Yadav BS
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of new N-benzyl-piperidine derivatives as multitarget-directed AChE/BuChE inhibitors for Alzheimer's disease.
    Conceição RAD; von Ranke N; Azevedo L; Franco D; Nadur NF; Kummerle AE; Barbosa MLC; Souza AMT
    J Cell Biochem; 2023 Nov; 124(11):1734-1748. PubMed ID: 37796142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tailored Modeling of Rivastigmine Derivatives as Dual Acetylcholinesterase and Butyrylcholinesterase Inhibitors for Alzheimer's Disease Treatment.
    Adeowo FY; Oyetunji TP; Ejalonibu MA; Ndagi U; Kumalo HM; Lawal MM
    Chem Biodivers; 2021 Nov; 18(11):e2100361. PubMed ID: 34547176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
    Larik FA; Shah MS; Saeed A; Shah HS; Channar PA; Bolte M; Iqbal J
    Int J Biol Macromol; 2018 Sep; 116():144-150. PubMed ID: 29729344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined QSAR, molecular docking and molecular dynamics study on new Acetylcholinesterase and Butyrylcholinesterase inhibitors.
    Daoud I; Melkemi N; Salah T; Ghalem S
    Comput Biol Chem; 2018 Jun; 74():304-326. PubMed ID: 29747032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation, identification, and quantification of Pentylcurcumene from Geophila repens: A new class of cholinesterase inhibitor for Alzheimer's disease.
    Dash UC; Kanhar S; Dixit A; Dandapat J; Sahoo AK
    Bioorg Chem; 2019 Jul; 88():102947. PubMed ID: 31028989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
    Gao H; Jiang Y; Zhan J; Sun Y
    Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore mapping of the crucial mediators of acetylcholinesterase and butyrylcholinesterase dual inhibition in Alzheimer's disease.
    Adeowo FY; Elrashedy AA; Ejalonibu MA; Lawal IA; Lawal MM; Kumalo HM
    Mol Divers; 2022 Oct; 26(5):2761-2774. PubMed ID: 35067751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivity of hamamelitannin, flavokawain A, and triacetyl resveratrol as natural compounds: Molecular docking study, anticolon cancer, and anti-Alzheimer potentials.
    Zhang M; Xue J; Chen X; Elsaid FG; Salem ET; Ghanem RA; El-Kott AF; Xu Z
    Biotechnol Appl Biochem; 2023 Apr; 70(2):730-745. PubMed ID: 35933706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
    Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
    CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Study of Benzimidazole-Based Oxazole Analogues: A Promising Acetylcholinesterase and Butyrylcholinesterase Inhibitors.
    Hussain R; Rahim F; Ullah H; Khan S; Sarfraz M; Iqbal R; Suleman F; Al-Sadoon MK
    Molecules; 2023 Oct; 28(20):. PubMed ID: 37894494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Computational Study of Natural Compounds from Bacopa monnieri in the Treatment of Alzheimer's Disease.
    Jamal QMS; Siddiqui MU; Alharbi AH; Albejaidi F; Akhtar S; Alzohairy MA; Kamal MA; Kesari KK
    Curr Pharm Des; 2020; 26(7):790-800. PubMed ID: 31894743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, biological evaluation and molecular docking of cyclic biguanidine compounds as cholinesterase inhibitors.
    Gungor O; Kose M
    J Biomol Struct Dyn; 2023 Dec; 41(20):10885-10899. PubMed ID: 36537267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the Role of Erythrina corallodendron L. in Alzheimer's Disease: in Vitro and in Silico Approach.
    Salem AM; Mostafa NM; Al-Sayed E; Fawzy IM; Singab ANB
    Chem Biodivers; 2023 Jul; 20(7):e202300200. PubMed ID: 37329524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-target approach for Alzheimer's disease treatment: computational biomolecular modeling of cholinesterase enzymes with a novel 4-
    Adeowo FY; Ejalonibu MA; Elrashedy AA; Lawal MM; Kumalo HM
    J Biomol Struct Dyn; 2021 Jul; 39(11):3825-3841. PubMed ID: 33030113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico modeling for dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes in Alzheimer's disease.
    Kumar V; Saha A; Roy K
    Comput Biol Chem; 2020 Oct; 88():107355. PubMed ID: 32801088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.
    Riazimontazer E; Sadeghpour H; Nadri H; Sakhteman A; Tüylü Küçükkılınç T; Miri R; Edraki N
    Bioorg Chem; 2019 Aug; 89():103006. PubMed ID: 31158577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Approaches to Evaluate the Acetylcholinesterase Binding Interaction with Taxifolin for the Management of Alzheimer's Disease.
    Ahmad V; Alotibi I; Alghamdi AA; Ahmad A; Jamal QMS; Srivastava S
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.